In previous studies, JWA has been identified as a common signaling molecule of the cell signal transduction pathways induced by cancer-promoting or tumor suppressor agents; moreover, it is significant in the regulation of the MAPK pathways (14–16). Here, ARL6IP5 is linked to cancer.